The impact of COVID-19 on DTP3 vaccination coverage in Europe (2012-2023)

Simple item page
dc.contributor.authorAguinaga Ontoso, Inés
dc.contributor.authorGuillén Aguinaga, Sara
dc.contributor.authorGuillén Aguinaga, Laura
dc.contributor.authorAlas Brun, Rosa María
dc.contributor.authorGuillén-Aguinaga, Miriam
dc.contributor.authorOnambele, Luc
dc.contributor.authorAguinaga Ontoso, Enrique
dc.contributor.authorRayón Valpuesta, Esperanza
dc.contributor.authorGuillén Grima, Francisco
dc.contributor.departmentCiencias de la Saludes_ES
dc.contributor.departmentOsasun Zientziakeu
dc.date.accessioned2025-02-26T09:31:14Z
dc.date.available2025-02-26T09:31:14Z
dc.date.issued2025-12-24
dc.date.updated2025-02-26T09:26:17Z
dc.description.abstractBackground: The COVID-19 pandemic disrupted routine child immunization efforts, threatening to reverse progress in controlling vaccine-preventable diseases. Materials and Methods: We analyzed the impact of COVID-19 on DTP3 vaccination in Europe by comparing trends before and after the pandemic using time series data from 2000 to 2023. Employing joinpoint regression, chi-square tests, and segmented regression analysis, we assessed DTP3 vaccination trends and coverage changes. Results: The findings revealed significant regional disparities across Europe. Statistical models indicated reductions in DTP3 coverage in countries such as Ireland, Sweden, and Switzerland, whereas Ukraine and San Marino showed improvements. Conclusions: There are variations in the effect of COVID-19 on DTP3 coverage rates, indicating the need for targeted public health strategies to address vaccine hesitancy, logistical barriers, and systemic inequities.en
dc.format.mimetypeapplication/pdfen
dc.identifier.citationAguinaga-Ontoso, I., Guillén-Aguinaga, S., Guillén-Aguinaga, L., Alas-Brun, R., Guillén-Aguinaga, M., Onambele, L., Aguinaga-Ontoso, E., Rayón-Valpuesta, E., Guillén-Grima, F. (2025). The impact of COVID-19 on DTP3 vaccination coverage in Europe (2012-2023). Vaccines, 13(1), 1-43. https://doi.org/10.3390/vaccines13010006.
dc.identifier.doi10.3390/vaccines13010006
dc.identifier.issn2076-393X
dc.identifier.urihttps://academica-e.unavarra.es/handle/2454/53578
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofVaccines (2025), vol. 13, núm. 1
dc.relation.publisherversionhttps://doi.org/10.3390/vaccines13010006
dc.rights© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectCOVID-19 pandemic impacten
dc.subjectDTP3 vaccinationen
dc.subjectEuropeen
dc.subjectvaccination trendsen
dc.titleThe impact of COVID-19 on DTP3 vaccination coverage in Europe (2012-2023)en
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication
relation.isAuthorOfPublicatione7178013-f5e6-4100-80b2-23f1d6cb6408
relation.isAuthorOfPublication359f165a-4c28-44bf-b931-6e5243be44db
relation.isAuthorOfPublication5512713c-5fd3-4806-a61b-2972921a9c6f
relation.isAuthorOfPublication9dc06ec2-d965-482c-9165-b1fcc9260d5a
relation.isAuthorOfPublicationdfbf180f-dd66-42b9-ba45-2de0b3a334d5
relation.isAuthorOfPublication.latestForDiscoverye7178013-f5e6-4100-80b2-23f1d6cb6408

Files

Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
Aguinaga_ImpactCOVID19.pdf
Size:
4.9 MB
Format:
Adobe Portable Document Format
Download
Thumbnail Image
Name:
Aguinaga_ImpactCovid_MatCompl.pdf
Size:
99.34 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Artículos de revista DCS - OZS Aldizkari artikuluak
Artículos de revista - Aldizkari artikuluak